IDXX
Price
$426.11
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
89 days until earnings call
TFX
Price
$195.58
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
99 days until earnings call
Ad is loading...

IDXX vs TFX

Header iconIDXX vs TFX Comparison
Open Charts IDXX vs TFXBanner chart's image
IDEXX Laboratories
Price$426.11
Change-$0.00 (-0.00%)
Volume$681.78K
CapitalizationN/A
Teleflex
Price$195.58
Change-$0.00 (-0.00%)
Volume$453.26K
CapitalizationN/A
IDXX vs TFX Comparison Chart
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IDXX vs. TFX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a StrongBuy and TFX is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (IDXX: $426.11 vs. TFX: $195.58)
Brand notoriety: IDXX and TFX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 118% vs. TFX: 118%
Market capitalization -- IDXX: $44.84B vs. TFX: $10.49B
IDXX [@Medical Specialties] is valued at $44.84B. TFX’s [@Medical Specialties] market capitalization is $10.49B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileTFX’s FA Score has 2 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • TFX’s FA Score: 2 green, 3 red.
According to our system of comparison, TFX is a better buy in the long-term than IDXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 5 TA indicator(s) are bullish while TFX’s TA Score has 4 bullish TA indicator(s).

  • IDXX’s TA Score: 5 bullish, 3 bearish.
  • TFX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IDXX is a better buy in the short-term than TFX.

Price Growth

IDXX (@Medical Specialties) experienced а +2.44% price change this week, while TFX (@Medical Specialties) price change was -3.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.07%. For the same industry, the average monthly price growth was +1.69%, and the average quarterly price growth was -3.31%.

Reported Earning Dates

IDXX is expected to report earnings on Feb 10, 2025.

TFX is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (-0.07% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than TFX($10.5B). IDXX has higher P/E ratio than TFX: IDXX (52.87) vs TFX (29.48). TFX YTD gains are higher at: -21.198 vs. IDXX (-23.230). IDXX has higher annual earnings (EBITDA): 1.22B vs. TFX (761M). IDXX has more cash in the bank: 454M vs. TFX (223M). IDXX has less debt than TFX: IDXX (1.07B) vs TFX (1.93B). IDXX has higher revenues than TFX: IDXX (3.66B) vs TFX (2.97B).
IDXXTFXIDXX / TFX
Capitalization44.8B10.5B427%
EBITDA1.22B761M160%
Gain YTD-23.230-21.198110%
P/E Ratio52.8729.48179%
Revenue3.66B2.97B123%
Total Cash454M223M204%
Total Debt1.07B1.93B55%
FUNDAMENTALS RATINGS
IDXX vs TFX: Fundamental Ratings
IDXX
TFX
OUTLOOK RATING
1..100
552
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
1881
PRICE GROWTH RATING
1..100
6363
P/E GROWTH RATING
1..100
7720
SEASONALITY SCORE
1..100
4285

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (18) in the Medical Specialties industry is significantly better than the same rating for IDXX (85). This means that TFX’s stock grew significantly faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (62) in the Medical Specialties industry is somewhat better than the same rating for TFX (100). This means that IDXX’s stock grew somewhat faster than TFX’s over the last 12 months.

IDXX's SMR Rating (18) in the Medical Specialties industry is somewhat better than the same rating for TFX (81). This means that IDXX’s stock grew somewhat faster than TFX’s over the last 12 months.

IDXX's Price Growth Rating (63) in the Medical Specialties industry is in the same range as TFX (63). This means that IDXX’s stock grew similarly to TFX’s over the last 12 months.

TFX's P/E Growth Rating (20) in the Medical Specialties industry is somewhat better than the same rating for IDXX (77). This means that TFX’s stock grew somewhat faster than IDXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXTFX
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 22 days ago
63%
Declines
ODDS (%)
Bearish Trend 16 days ago
68%
Bearish Trend 6 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOEV0.740.05
+6.52%
Canoo
EWTX35.22-0.11
-0.31%
Edgewise Therapeutics
IEX227.97-1.37
-0.60%
IDEX Corp
DXPE69.95-0.78
-1.10%
DXP Enterprises
NLSP3.90-0.07
-1.76%
Nls Pharmaceutics Ltd

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with MYGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
-2.56%
MYGN - IDXX
48%
Loosely correlated
-6.53%
TMO - IDXX
45%
Loosely correlated
-1.13%
WAT - IDXX
42%
Loosely correlated
+1.33%
IQV - IDXX
42%
Loosely correlated
-1.58%
ALGN - IDXX
41%
Loosely correlated
-2.73%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with SNN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then SNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-1.23%
SNN - TFX
59%
Loosely correlated
-0.65%
MDT - TFX
49%
Loosely correlated
+0.03%
IDXX - TFX
46%
Loosely correlated
-2.56%
WAT - TFX
44%
Loosely correlated
+1.33%
ICUI - TFX
41%
Loosely correlated
-0.22%
More